The UK is falling behind on life science investments, trade group warns news2025-09-11T14:17:12+00:00September 11th, 2025|Endpoints News|
A conversation with Lasker Award winner Michael Welsh on life-saving cystic fibrosis drugsnews2025-09-11T13:18:56+00:00September 11th, 2025|Endpoints News|
Sophont raises $9.2M to build multimodal foundation modelsnews2025-09-11T13:00:30+00:00September 11th, 2025|Endpoints News|
SEC files charges against former FibroGen CMO for manipulating clinical trial datanews2025-09-11T11:09:03+00:00September 11th, 2025|Endpoints News|
Revolution’s lead RAS blocker heads into Phase 3 in frontline pancreatic cancer after early datanews2025-09-11T11:01:24+00:00September 11th, 2025|Endpoints News|
Exclusive: Robotics startup Medra raises $11M to automate labsnews2025-09-11T11:00:23+00:00September 11th, 2025|Endpoints News|
Patient dies in Capsida study for rare brain disordernews2025-09-11T07:20:19+00:00September 11th, 2025|Endpoints News|
LB Pharma prices $285M Nasdaq debut to help develop schizophrenia drugnews2025-09-11T02:45:27+00:00September 11th, 2025|Endpoints News|
Merck cancels plans for $1.3B London labnews2025-09-10T19:43:00+00:00September 10th, 2025|Endpoints News|
Biocon eyes generic semaglutide market for 2026news2025-09-10T19:00:54+00:00September 10th, 2025|Endpoints News|
